A61P 19/02
Drugs for skeletal disorders: for joint disorders
Official title: for joint disorders, e.g. arthritis, arthrosis
A61P19/02 (Drugs for skeletal disorders: for joint disorders) appears on 22,514 US grants and 35,183 published applications in this corpus.
Search patents in A61P- Granted patents
- 22,514
- Published applications
- 35,183
- Assignees
- 7,267
- Inventors
- 46,455
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 6 | 0 |
| 1994 | 22 | 0 |
| 1995 | 16 | 0 |
| 1996 | 23 | 0 |
| 1997 | 72 | 0 |
| 1998 | 92 | 0 |
| 1999 | 173 | 0 |
| 2000 | 231 | 0 |
| 2001 | 361 | 90 |
| 2002 | 434 | 677 |
| 2003 | 502 | 1204 |
| 2004 | 425 | 1567 |
| 2005 | 489 | 1590 |
| 2006 | 644 | 1585 |
| 2007 | 702 | 1685 |
| 2008 | 773 | 1980 |
| 2009 | 928 | 2239 |
| 2010 | 1257 | 2549 |
| 2011 | 1335 | 2356 |
| 2012 | 1568 | 2202 |
| 2013 | 1711 | 1712 |
| 2014 | 1546 | 1836 |
| 2015 | 1373 | 1608 |
| 2016 | 1202 | 1553 |
| 2017 | 1238 | 1426 |
| 2018 | 979 | 1249 |
| 2019 | 1002 | 1227 |
| 2020 | 853 | 1046 |
| 2021 | 671 | 889 |
| 2022 | 515 | 772 |
| 2023 | 406 | 649 |
| 2024 | 377 | 596 |
| 2025 | 362 | 559 |
| 2026 | 215 | 337 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Use of porous calcium-based granules for promoting healing of an intra-articular or peri-articular fracture of a fractured bone6 Oct 2026US 12,751,970 B2Joy Medical Devices Corporation
- Protein with anti-inflammatory properties6 Oct 2026US 12,753,214 B2Revolo Biotherapeutics Limited
- Aggrecan binding immunoglobulins6 Oct 2026US 12,753,224 B2Ablynx N. V.
- Glutarimide compound and use thereof22 Sep 2026US 12,741,031 B2Medshine Discovery Inc.
- Method for manufacturing mitochondria-rich plasma22 Sep 2026US 12,741,068 B2Taiwan Mitochondrion Applied Technology Co., Ltd.
- Methods of preventing post-traumatic osteoarthritis using metformin8 Oct 2026US 2026/0306428 A1
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Methods of treating rheumatoid arthritis, chronic spontaneous urticaria, and systemic lupus erythematosis using an inhibitor of bruton's tyrosine kinase8 Oct 2026US 2026/0306487 A1Genentech, Inc.
- Combination therapy comprising a composition of mesenchymal stromal cells and hyaluronic acid for use in treatment of osteoarthritis8 Oct 2026US 2026/0306547 A1Stempeutics Research Private Limited
- Composition including propionibacterium freudenreichii mj2 strainderived extracellular vesicles or chaperonin protein as active ingredient for prevention, alleviation, or treatment of rheumatoid arthritis8 Oct 2026US 2026/0306557 A1Korea University Research and Business Foundation
Most cited
By later US patents
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,259US 5,530,101 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,030US 5,693,762 AProtein Design Labs, Inc. · 1997
- Humanized immunoglobulins and methods of making the same1,467US 6,180,370 B2Protein Design Labs, Inc. · 2001
- Sustained release systems of ascorbic acid phosphate1,391US 8,034,363 B2Advanced Technologies and Regenerative Medicine, LLC · 2011